BusinessAxsome Announces CREATE-1 Interim Analysis Expected Year-End 2017By Nasdaq OMXSep 7, 2017, 11:00 AM UTC
BusinessAxsome Therapeutics Announces Publication of Research Showing AXS-02 Inhibits Pain in Animal Model of Complex Regional Pain SyndromeBy Nasdaq OMXOct 4, 2016, 11:01 AM UTC
BusinessAxsome Therapeutics Receives New U.S. Patent Covering AXS-02 for the Treatment of Complex Regional Pain SyndromeBy Nasdaq OMXMar 15, 2016, 11:00 AM UTC
